The estimated Net Worth of Thomas J Neff is at least $9.15 Milion dollars as of 30 November 2022. Thomas Neff owns over 1,207 units of Accolade stock worth over $158,543 and over the last 4 years Thomas sold ACCD stock worth over $8,991,930.
Thomas has made over 27 trades of the Accolade stock since 2020, according to the Form 4 filled with the SEC. Most recently Thomas exercised 1,207 units of ACCD stock worth $4,719 on 30 November 2022.
The largest trade Thomas's ever made was selling 161,522 units of Accolade stock on 20 January 2021 worth over $8,991,930. On average, Thomas trades about 6,026 units every 23 days since 2020. As of 30 November 2022 Thomas still owns at least 40,548 units of Accolade stock.
You can see the complete history of Thomas Neff stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O ACCOLADE, INC., 1201 THIRD AVENUE, SUITE 1700, SEATTLE, WA, 98101.
Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan oraz Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Accolade executives and other stock owners filed with the SEC include: